Incorporating innovative B-cell targeting therapeutics into a combined-modality bridging approach followed by timely consolidative haploidentical transplantation to salvage a pediatric patient with relapsed/refractory diffuse large B-cell lymphoma.
Yu-Ju ChaoPei-Ing LeeTzu-Hsien YangLi-Hua FangYu-Chun TsaiMing-Yuan LeeYun-Hsin WangLiuh-Yow ChenRong-Long ChenPublished in: Pediatric blood & cancer (2024)